MUMBAI, Aug 1 (Reuters Breakingviews) - Private equity giant EQT (EQTAB.ST) is buying a majority stake in the country’s largest fertility clinic chain Indira IVF via its Asian unit BPEA EQT, valuing the firm at $1.1 billion.
Indira IVF serves some of the 15% of Indian couples experiencing infertility, a problem on the rise in the world’s most populous country as people marry later and air pollution stifles the ability to conceive naturally.
EQT’s deal also is another bet on the changing demands of the South Asian nation’s middle class.
Thanks to the gradual maturing of the private equity business, both purchases come with the added benefit of the buyer taking control.
They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.
Persons:
Indira, EQT’s, Shritama Bose, Steve Cohen, ’, Una Galani, Aditya Munjuluru
Organizations:
Reuters, Blackstone, HDFC, Twitter, Sequoia, Walmart, Thomson
Locations:
MUMBAI, Temasek